TrialThe New England journal of medicine2021
Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine.
Jerald Sadoff et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
724 papers cite itlatest 60 shown
this paperpooled ittrialcites it